poolware black spot algaecide
poolware pty ltd - copper present as a complex blend of copper salts; benzalkonium chloride - aqueous concentrate - copper present as a complex blend of copper salts mineral-copper-salt active 32.0 g/l; benzalkonium chloride ammonium-quaternary active 200.0 g/l - pool algicide - swimming pool - black spot algae
algon's winteriser algaecide
algon australia pty limited - copper present as a complex blend of copper salts - aqueous concentrate - copper present as a complex blend of copper salts mineral-copper-salt active 40.0 g/l - pool algicide - pool - algae
pontacid forte tablets (pom)
mefenamic acid 500mg
procold flu tablets
paracetamol 500mg,pseudoephedrine hydrochloride 30mg,chlorpheniramine maleate 2mg
broadced injection (pom)
ceftriaxone disodium 1g + 10ml water for injection
pms-flunisolide spray
pharmascience inc - flunisolide - spray - 0.025% - flunisolide 0.025% - corticosteroids
selepen solution
pharmaceutical partners of canada inc - selenium (selenious acid) - solution - 40mcg - selenium (selenious acid) 40mcg - replacement preparations
l-methyl-b6-b12- levomefolate calcium, pyridoxal phosphate anhydrous, and methylcobalamin tablet, coated
virtus pharmaceuticals llc - levomefolate calcium (unii: a9r10k3f2f) (levomefolic acid - unii:8s95dh25xc), pyridoxal phosphate anhydrous (unii: f06sge49m6) (pyridoxal phosphate anhydrous - unii:f06sge49m6), methylcobalamin (unii: br1sn1js2w) (methylcobalamin - unii:br1sn1js2w) - levomefolate calcium 3 mg - there have been rare reports of hypersensitivity (allergic-like reactions) to l-methyl-b6-b12 tablets . therefore, a known hypersensitivity to any of the components in the product is a contraindication to its use for any indication.
l-methyl-mc-nac- levomefolate calcium, methylcobalamin, and acetylcysteine tablet, coated
virtus pharmaceuticals llc - levomefolate calcium (unii: a9r10k3f2f) (levomefolic acid - unii:8s95dh25xc), methylcobalamin (unii: br1sn1js2w) (methylcobalamin - unii:br1sn1js2w), acetylcysteine (unii: wyq7n0bpyc) (acetylcysteine - unii:wyq7n0bpyc) - levomefolate calcium 6 mg - l-methyl-mc-nac tablets is indicated for the distinct nutritional requirements of individuals under a physician's treatment for early memory loss 25 with particular emphasis for those individuals diagnosed with or at risk for neurovascular oxidative stress 14,16,18 and/or hyperhomocysteinemia 18 ; mild to moderate cognitive impairment with or without vitamin b12 deficiency 9,13,19 , vascular dementia 12,13,21 or alzheimer's disease 12,13,16,21 . l-methyl-mc-nac tablets should always be used under medical supervision. there have been rare reports of hypersensitivity (allergic-like reactions) to l-methyl-mc-nac tablets. therefore, a known hypersensitivity to any components in the product is a contraindication to its use for any indication.